¿Qué es la vigilancia activa en patología tumoral maligna tiroidea? ¿Cuáles son las barreras para implementarla ampliamente en la Argentina?
DOI:
https://doi.org/10.51987/revhospitalbaires.v41i2.91Palabras clave:
humanos, neoplasias de la tiroides/terapia, espera vigilante/estadística & datos numéricos, argentina, calidad de vida, neoplasia de la tiroides/psicología, progresión de la enfermedadResumen
.
Descargas
Referencias
Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010;34:1222- 1231. DOI: https://doi.org/10.1007/s00268-009-0359-x
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24:27-34. DOI: https://doi.org/10.1089/thy.2013.0367
Oda H, Miyauchi A, Ito Y, et al. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Thyroid 2016;26:150-155. DOI: https://doi.org/10.1089/thy.2015.0313
Kwon H, Oh HS, Kim M, et al. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea. J Clin Endocrinol Metab 2017;102:1917-1925. DOI: https://doi.org/10.1210/jc.2016-4026
Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg 2017; 143:1015-1020. DOI: https://doi.org/10.1001/jamaoto.2017.1442
Ramundo V, Sponziello M, Falcone R, et al. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach. J Surg Oncol 2020; 121:958-963. DOI: https://doi.org/10.1002/jso.25848
Sakai T, Sugitani I, Ebina A, et al. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma. Thyroid 2019; 29:59- 63 DOI: https://doi.org/10.1089/thy.2018.0462
Smulever A, Pitoia F. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab 2019; 63:462-469. DOI: https://doi.org/10.20945/2359-3997000000168
Molinaro E, Campopiano MC, Pieruzzi L, et al. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center. J Clin Endocrinol Metab 2020;105(3): e172-e180. DOI: https://doi.org/10.1210/clinem/dgz113
Smulever A, Pitoia F. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance. Endocrine. 2020; 69(3):587-59. DOI: https://doi.org/10.1007/s12020-020-02310-8
Pitoia F, Smulever A. “Vigilancia activa encubierta” y los costos de la ausencia de implementación de la “cirugía diferida” en Argentina. Rev Arg
Descargas
Compartir artículo
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Instituto Universitario Hospital Italiano de Buenos Aires
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
